Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-12

Clinical Trial Update: Phase 2B/3 Double-blinded Placebo-controlled [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 double-blinded placebo-controlled trial for Chlamydia trachomatis infection sponsored by Evofem Inc; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Evofem Inc. | Conditions: Chlamydia Trachomatis Infection | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-08-12